Dorota Schranz

Keine laufenden Positionen mehr

Finance

Profil

Dorota Schranz worked as the Director of Biomarker Development and Validation at NorWesTech, Inc. from 2005 to 2012.

Unternehmen	Position	Ende
NorWesTech, Inc. NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.	Corporate Officer/Principal	09.03.2012

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Private Unternehmen	1
NorWesTech, Inc. NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA.	Finance

Private Unternehmen

Finance